Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study [NA]

View source ↗

Summary

Life on the Go 3 is an automated, personalized physical activity program being studied to improve immune function and clinical outcomes in women with stage II-I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma | NA | Status: RECRUITING